Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1253939
Max Phase: Preclinical
Molecular Formula: C19H22N2O
Molecular Weight: 294.40
Molecule Type: Small molecule
Associated Items:
ID: ALA1253939
Max Phase: Preclinical
Molecular Formula: C19H22N2O
Molecular Weight: 294.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C1C(CC(C)C)=C(C#N)C(=O)N1c1c(C)cc(C)cc1C
Standard InChI: InChI=1S/C19H22N2O/c1-11(2)7-16-15(6)21(19(22)17(16)10-20)18-13(4)8-12(3)9-14(18)5/h8-9,11H,6-7H2,1-5H3
Standard InChI Key: OITFROHSZHTQCD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 294.40 | Molecular Weight (Monoisotopic): 294.1732 | AlogP: 4.34 | #Rotatable Bonds: 3 |
Polar Surface Area: 44.10 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.45 | CX LogD: 4.45 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.83 | Np Likeness Score: -0.45 |
1. Birru W, Fernley RT, Graham LD, Grusovin J, Hill RJ, Hofmann A, Howell L, James PJ, Jarvis KE, Johnson WM, Jones DA, Leitner C, Liepa AJ, Lovrecz GO, Lu L, Nearn RH, O'Driscoll BJ, Phan T, Pollard M, Turner KA, Winkler DA.. (2010) Synthesis, binding and bioactivity of gamma-methylene gamma-lactam ecdysone receptor ligands: advantages of QSAR models for flexible receptors., 18 (15): [PMID:20619664] [10.1016/j.bmc.2010.06.020] |
Source(1):